Vimseltinib Alternatives Compared

View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Vimseltinib	Turalio (pexidartinib)	Pexidartinib	Enter another drug to compare

View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Vimseltinib	Turalio (pexidartinib)	Pexidartinib	Enter another drug to compare
Prescription only Prescribed for Tenosynovial Giant Cell Tumor. Vimseltinib may also be used for purposes not listed in this medication guide.	Prescription only Prescribed for Tenosynovial Giant Cell Tumor. Turalio may also be used for purposes not listed in this medication guide.	Prescription only Prescribed for Tenosynovial Giant Cell Tumor. Pexidartinib may also be used for purposes not listed in this medication guide.	Related suggestions Tenosynovial Giant Cell Tumor Romvimza
More about Vimseltinib	More about Turalio (pexidartinib)	More about Pexidartinib
Ratings & Reviews
Be the first to share your experience with this drug.	Be the first to share your experience with this drug.	Pexidartinib has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect.
Review this drug	Review this drug	View all 1 reviews
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified.
View all Vimseltinib side effects	View all Turalio side effects	View all Pexidartinib side effects
Drug Class
Miscellaneous antineoplastics	Multikinase inhibitors	Multikinase inhibitors
Generic Availability
N/A	No lower cost generic approved	N/A
Pricing and Coupons * Prices are without insurance
We could not find an exact match for this medicine. Try searching the Price Guide directly.	We could not find an exact match for this medicine. Try searching the Price Guide directly.	We could not find an exact match for this medicine. Try searching the Price Guide directly.
Get free Discount Card	Get free Discount Card	Get free Discount Card

Dosage Forms
N/A	Oral capsule	N/A
Brand Names
Romvimza	N/A	Turalio
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value.
144 hours	26.6 hours	26.6 hours
CSA Schedule ¹ View glossary of CSA terms
N Not a controlled drug Is not subject to the Controlled Substances Act.	N Not a controlled drug Is not subject to the Controlled Substances Act.	N Not a controlled drug Is not subject to the Controlled Substances Act.
Pregnancy Category
Summary unavailable. See the full pregnancy warnings document.	Summary unavailable. See the full pregnancy warnings document.	Summary unavailable. See the full pregnancy warnings document.
Drug Interactions
A total of 135 drugs are known to interact with Vimseltinib: 15 major drug interactions (66 brand and generic names) 114 moderate drug interactions (400 brand and generic names) 6 minor drug interactions (12 brand and generic names)	A total of 648 drugs are known to interact with Turalio: 424 major drug interactions (1724 brand and generic names) 208 moderate drug interactions (849 brand and generic names) 16 minor drug interactions (47 brand and generic names)	A total of 648 drugs are known to interact with Pexidartinib: 424 major drug interactions (1724 brand and generic names) 208 moderate drug interactions (849 brand and generic names) 16 minor drug interactions (47 brand and generic names)
Alcohol/Food/Lifestyle Interactions
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider.	You may experience reduced absorption of pexidartinib in the presence of food. Pexidartinib should... View more Pexidartinib may cause liver injury, and using it with other medications that can also affect the... View more	You may experience reduced absorption of pexidartinib in the presence of food. Pexidartinib should... View more Pexidartinib may cause liver injury, and using it with other medications that can also affect the... View more
Disease Interactions
Liver disease Renal dysfunction	Hepatic dysfunction Renal Impairment	Hepatic dysfunction Renal Impairment
First Approval Date
February 14, 2025	August 02, 2019	August 02, 2019
WADA Class View classifications
N/A	N/A	N/A
More Information
Side effects Drug interactions Dosage Pregnancy warnings En español	Side effects Drug interactions Dosage Pricing and coupons Pregnancy warnings Breastfeeding warnings Drug images En español	Side effects Drug interactions Dosage Pregnancy warnings Breastfeeding warnings En español
Patient Resources
Vimseltinib uses	Turalio uses	Pexidartinib uses Advanced reading
Professional Resources
Monograph (AHFS) Prescribing information	Prescribing information	Monograph (AHFS) Prescribing information
Related Treatment Guide
Tenosynovial Giant Cell Tumor	Tenosynovial Giant Cell Tumor	Tenosynovial Giant Cell Tumor

¹ The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Vimseltinib Alternatives Compared

See also:

Romvimza

Turalio

Ozempic

Abecma

Accutane

Adstiladrin

Amnesteem

Amtagvi

Anktiva

Pexidartinib

Further information

Vimseltinib Alternatives Compared

See also:

Further information

Compare Drugs